An open-label, dose-escalation and multi-center study to evaluate the safety and pharmacokinetics of SAR650984 in patients with relapsed/refractory multiple myeloma

Type of Cancer
Multiple Myeloma

Site
Hackensack

Sponsor
Sanofi Aventis

Protocol Number
TED14154

To Learn More Call
201-510-0910